SunOpta Inc. (STKL) Director Richard Dean Hollis Purchases 50,000 Shares of Stock
SunOpta Inc. (NASDAQ:STKL) (TSE:SOY) Director Richard Dean Hollis acquired 50,000 shares of SunOpta stock in a transaction on Friday, November 11th. The stock was acquired at an average cost of $6.55 per share, for a total transaction of $327,500.00. Following the completion of the purchase, the director now owns 50,000 shares of the company’s stock, valued at approximately $327,500. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of SunOpta Inc. (NASDAQ:STKL) remained flat at $7.35 during trading on Thursday. 107,352 shares of the company’s stock traded hands. SunOpta Inc. has a 52-week low of $3.16 and a 52-week high of $7.50. The firm’s market cap is $629.58 billion. The firm has a 50 day moving average of $6.70 and a 200 day moving average of $5.70.
SunOpta (NASDAQ:STKL) last posted its quarterly earnings results on Wednesday, November 9th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.06 by $0.01. The firm had revenue of $348.73 million for the quarter, compared to the consensus estimate of $360.50 million. SunOpta had a negative net margin of 3.50% and a positive return on equity of 3.75%. The business’s revenue was up 25.8% compared to the same quarter last year. During the same period last year, the firm posted $0.07 earnings per share. Analysts forecast that SunOpta Inc. will post $0.20 earnings per share for the current year.
Several hedge funds and other institutional investors have recently bought and sold shares of STKL. UBS Group AG increased its position in SunOpta by 16.9% in the third quarter. UBS Group AG now owns 3,678,363 shares of the company’s stock valued at $25,969,000 after buying an additional 531,783 shares during the period. Ardsley Advisory Partners purchased a new position in shares of SunOpta during the third quarter valued at approximately $25,628,000. Empyrean Capital Partners LP increased its position in shares of SunOpta by 54.8% in the third quarter. Empyrean Capital Partners LP now owns 1,548,000 shares of the company’s stock valued at $10,929,000 after buying an additional 548,000 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of SunOpta by 10.3% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,809,279 shares of the company’s stock valued at $12,762,000 after buying an additional 169,201 shares during the last quarter. Finally, Morgan Stanley increased its position in shares of SunOpta by 1.1% in the third quarter. Morgan Stanley now owns 8,023,782 shares of the company’s stock valued at $56,648,000 after buying an additional 89,567 shares during the last quarter. 71.17% of the stock is currently owned by hedge funds and other institutional investors.
Several equities research analysts have weighed in on STKL shares. TheStreet upgraded shares of SunOpta from a “sell” rating to a “hold” rating in a report on Wednesday, August 3rd. Citigroup Inc. lifted their price objective on shares of SunOpta from $5.50 to $8.00 and gave the company a “buy” rating in a research report on Friday, September 9th. Zacks Investment Research upgraded SunOpta from a “sell” rating to a “hold” rating in a research note on Tuesday, August 2nd. Wunderlich initiated coverage on SunOpta in a research note on Tuesday, October 11th. They issued a “buy” rating and a $10.00 target price on the stock. Finally, DA Davidson increased their target price on SunOpta from $7.00 to $7.50 and gave the stock a “buy” rating in a research note on Thursday, August 11th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $8.88.
SunOpta Inc operates businesses focused on a healthy products portfolio. The Company operates through two segments: Global Ingredients and Consumer Products. Its Global Ingredients segment aggregates its North American and international raw material sourcing and supply operating segments focused on the procurement, processing and sale of specialty and organic grains and seeds, fruits, grain- and cocoa-based ingredients, and other commodities.
Receive News & Stock Ratings for SunOpta Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta Inc. and related stocks with our FREE daily email newsletter.